Intervention Protocol

You have free access to this content

Melatonin for women in pregnancy for neuroprotection of the fetus

  1. Dominic Wilkinson1,*,
  2. Emily Bain2,
  3. Euan Wallace3

Editorial Group: Cochrane Pregnancy and Childbirth Group

Published Online: 31 MAY 2013

DOI: 10.1002/14651858.CD010527


How to Cite

Wilkinson D, Bain E, Wallace E. Melatonin for women in pregnancy for neuroprotection of the fetus (Protocol). Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD010527. DOI: 10.1002/14651858.CD010527.

Author Information

  1. 1

    Women's and Children's Hospital, University of Adelaide, Discipline of Obstetrics and Gynecology, North Adelaide, SA, Australia

  2. 2

    The University of Adelaide, ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology, Adelaide, South Australia, Australia

  3. 3

    Monash University, Department of Obstetrics and Gynaecology, Monash, Victoria, Australia

*Dominic Wilkinson, Discipline of Obstetrics and Gynecology, Women's and Children's Hospital, University of Adelaide, 72 King William Road, North Adelaide, SA, 5006, Australia. dominic.wilkinson@adelaide.edu.au.

Publication History

  1. Publication Status: New
  2. Published Online: 31 MAY 2013

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of melatonin when used for neuroprotection of the fetus.